Home › Macular Degeneration › Washington › Spokane
Macular Degeneration clinical trials in Spokane, WA
5 studies for Macular Degeneration are looking for participants at sites in and around Spokane (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Clinical Trial of EYE201/MK-8748 in People With Macular Degeneration (MK-8748-002)
RecruitingPhase 2/3
- Spokane Eye Clinical Research (Site 075), Spokane
A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)
RecruitingPhase 2/3
- Spokane Eye Clinical Research, Spokane
A Phase 1/2 Study of the Safety and Efficacy of BRX011 Oral Administration Once Daily in Subjects With Geographic Atrophy Secondary to Age-Related Macular Degeneration
RecruitingPhase 1/2
- Spokane Eye Clinic, Spokane
A Study Investigating Subcutaneously Administered Pozelimab in Combination With Cemdisiran or Cemdisiran Alone in Adult Participants With Geographic Atrophy
RecruitingPhase 3
- Spokane Eye Clinical Research, Spokane
A Study of the Safety and Tolerability of ASP7317 in Senior Adults Who Are Losing Their Clear, Sharp Central Vision Due to Geographic Atrophy Secondary to Dry Age-related Macular Degeneration
RecruitingPhase 1
- Spokane Eye Clinical Research, Spokane
About Macular Degeneration
Macular degeneration, or age-related macular degeneration (AMD), causes vision loss in older adults. Learn about the types and what can help.
More about Macular Degeneration on MedlinePlus
Macular Degeneration trials in other cities
- Dallas, TX13 studies
- Erie, PA10 studies
- The Woodlands, TX9 studies
- Sacramento, CA8 studies
- Hagerstown, MD8 studies
- Reno, NV8 studies
- Phoenix, AZ7 studies
- Cleveland, OH7 studies
- Houston, TX7 studies
- Salt Lake City, UT7 studies
- Boston, MA7 studies
- Austin, TX7 studies
Other studies in Spokane
- Non-Small Cell Lung Cancer12 studies
- Breast Cancer8 studies
- Ovarian Cancer8 studies
- Colorectal Cancer8 studies
- Parkinson's Disease7 studies
- Prostate Cancer6 studies
- Chronic Lymphocytic Leukemia6 studies
- Head and Neck Squamous Cell Carcinoma6 studies
- Cancer (all types)6 studies
- Triple-Negative Breast Cancer5 studies
- Melanoma5 studies
- Geographic Atrophy5 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.